Oncology Nurse AdvisorProstate Cancer Care: A Nurse’s Guide to Screening and Treatment

🎓 Expert Commentary / Peer Perspective

Prostate cancer remains the most common non-skin cancer among men worldwide. Outcomes vary dramatically by stage at diagnosis, with localized disease demonstrating nearly 100% 5-year survival, underscoring the importance of appropriate screening, risk assessment, and early intervention.

Clinical Considerations

• Family history, age, inherited genetic mutations, and race/ethnicity influence prostate cancer risk and may justify earlier screening discussions.
• PSA testing and digital rectal examination remain central screening tools, while staging incorporates PSA level, Gleason Grade Group, tumor stage, and biopsy findings.
• Treatment selection depends on risk stratification and disease stage, ranging from active surveillance for low-risk disease to multimodal treatment for advanced cancer.
• Germline testing and tumor profiling increasingly guide precision treatment decisions, including targeted therapy, immunotherapy, and clinical trial eligibility.
• Quality-of-life goals should be considered alongside clinical factors when selecting treatment strategies.

Practice Applications

• Educate patients about prostate cancer risk factors, screening options, and early detection benefits.
• Assess family history and genetic risk factors that may influence screening or treatment decisions.
• Support adherence to surveillance, treatment, and follow-up plans throughout the care continuum.
• Monitor treatment-related toxicities, symptoms, and psychosocial concerns.
• Coordinate multidisciplinary care and survivorship planning across treatment settings.